Evoke Pharma, Inc. (EVOK)

USD 3.09

(6.19%)

Revenue Summary of Evoke Pharma, Inc.

  • Evoke Pharma, Inc.'s latest annual revenue in 2023 was 5.18 Million USD , up 106.51% from previous year.
  • Evoke Pharma, Inc.'s latest quarterly revenue in 2024 Q2 was 2.55 Million USD , up 47.01% from previous quarter.
  • Evoke Pharma, Inc. reported a annual revenue of 2.5 Million USD in annual revenue 2022, up 55.04% from previous year.
  • Evoke Pharma, Inc. reported a annual revenue of 1.61 Million USD in annual revenue 2021, up 6929.0% from previous year.
  • Evoke Pharma, Inc. reported a quarterly revenue of 1.73 Million USD for 2024 Q1, up 3.55% from previous quarter.
  • Evoke Pharma, Inc. reported a quarterly revenue of 5.18 Million USD for 2023 FY, up 106.51% from previous quarter.

Annual Revenue Chart of Evoke Pharma, Inc. (2023 - 2011)

Historical Annual Revenue of Evoke Pharma, Inc. (2023 - 2011)

Year Revenue Revenue Growth
2023 5.18 Million USD 106.51%
2022 2.5 Million USD 55.04%
2021 1.61 Million USD 6929.0%
2020 23.02 Thousand USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%

Peer Revenue Comparison of Evoke Pharma, Inc.

Name Revenue Revenue Difference
Esperion Therapeutics, Inc. 116.33 Million USD 95.547%
Theratechnologies Inc. 81.76 Million USD 93.664%
Safety Shot Inc 202.67 Thousand USD -2456.19%
Cosmos Health Inc. 53.37 Million USD 90.294%
Cronos Group Inc. 88.84 Million USD 94.169%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD 98.83%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Organogenesis Holdings Inc. 433.14 Million USD 98.804%
Universe Pharmaceuticals INC 32.3 Million USD 83.965%
ProPhase Labs, Inc. 44.38 Million USD 88.328%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD 59.32%
Dynavax Technologies Corporation 232.28 Million USD 97.77%
Radius Health, Inc. 2.88 Billion USD 99.82%
China SXT Pharmaceuticals, Inc. 1.92 Million USD -168.636%
Alvotech 91.43 Million USD 94.334%
Sunshine Biopharma, Inc. 24.09 Million USD 78.497%
Alpha Teknova, Inc. 36.68 Million USD 85.878%
Intra-Cellular Therapies, Inc. 464.37 Million USD 98.884%
SCYNEXIS, Inc. 140.14 Million USD 96.303%
Harrow Health, Inc. 130.19 Million USD 96.021%
Biofrontera Inc. 34.07 Million USD 84.795%
DURECT Corporation 8.54 Million USD 39.394%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 99.147%
ANI Pharmaceuticals, Inc. 486.81 Million USD 98.936%
OptiNose, Inc. 70.98 Million USD 92.702%
RedHill Biopharma Ltd. 6.51 Million USD 20.459%
Aquestive Therapeutics, Inc. 50.58 Million USD 89.758%
Cumberland Pharmaceuticals Inc. 39.55 Million USD 86.902%
SIGA Technologies, Inc. 139.91 Million USD 96.297%
Lifecore Biomedical, Inc. 128.26 Million USD 95.961%
Shineco, Inc. 9.8 Million USD 47.146%
Phibro Animal Health Corporation 1.01 Billion USD 99.491%
Procaps Group S.A. 409.92 Million USD 98.736%
TherapeuticsMD, Inc. 1.3 Million USD -297.898%
Regencell Bioscience Holdings Limited - USD -Infinity%
Viatris Inc. 15.42 Billion USD 99.966%
Sunshine Biopharma, Inc. 24.09 Million USD 78.497%
Rockwell Medical, Inc. 83.61 Million USD 93.804%
Incannex Healthcare Limited 12 Thousand USD -43071.917%
Aytu BioPharma, Inc. 81 Million USD 93.604%
Tilray Brands, Inc. 788.94 Million USD 99.343%
Collegium Pharmaceutical, Inc. 566.76 Million USD 99.086%
PetIQ, Inc. 1.1 Billion USD 99.53%
Silver Spike Investment Corp. 11.72 Million USD 55.805%
Neurocrine Biosciences, Inc. 1.88 Billion USD 99.725%
Journey Medical Corporation 79.18 Million USD 93.457%
Alimera Sciences, Inc. 80.75 Million USD 93.585%
Petros Pharmaceuticals, Inc. 5.82 Million USD 11.022%
Assertio Holdings, Inc. 152.06 Million USD 96.593%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Embecta Corp. 1.12 Billion USD 99.538%
Cyclo Therapeutics, Inc. 1.07 Million USD -381.29%
Procaps Group, S.A. 409.92 Million USD 98.736%
PainReform Ltd. - USD -Infinity%
Avadel Pharmaceuticals plc 27.96 Million USD 81.473%
Hempacco Co., Inc. 4.04 Million USD -28.055%
Talphera, Inc. 651 Thousand USD -695.796%
Pacira BioSciences, Inc. 674.97 Million USD 99.232%
Alvotech 91.43 Million USD 94.334%
Lantheus Holdings, Inc. 1.29 Billion USD 99.6%
Kamada Ltd. 144.75 Million USD 96.421%
Indivior PLC 1.09 Billion USD 99.526%
Currenc Group, Inc. 53.25 Million USD 90.272%
Flora Growth Corp. 76.07 Million USD 93.19%
Cyclo Therapeutics, Inc. 1.07 Million USD -381.29%
Evolus, Inc. 202.08 Million USD 97.436%
HUTCHMED (China) Limited 837.99 Million USD 99.382%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD 99.196%
Akanda Corp. 2.16 Million USD -139.838%